These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8360847)

  • 1. Pharmacokinetics of (Me)Arg-Lys-Pro-Trp-tert-Leu-Leu-OEt and (Me)Arg-Lys-Pro-Trp-tert-Leu-Leu administered intravenously to beagle dogs.
    Tokumura T; Machida R; Tsuchiya Y; Sasaki A; Abe K; Tanaka T; Saeki Y
    J Pharm Sci; 1993 Jul; 82(7):725-8. PubMed ID: 8360847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of novel hexapeptides with neurotensin activity in rats.
    Machida R; Tokumura T; Tsuchiya Y; Sasaki A; Abe K
    Biol Pharm Bull; 1993 Jan; 16(1):43-7. PubMed ID: 8369751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-performance liquid chromatographic determination of (Me)Arg-Lys-Pro-Trp-tert.-Leu-Leu in plasma.
    Machida R; Tokumura T; Sasaki A; Tsuchiya Y; Abe K
    J Chromatogr; 1990 Dec; 534():190-5. PubMed ID: 2094706
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and biological effects of c(Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu) (JMV2012), a new analogue of neurotensin that crosses the blood-brain barrier.
    Bredeloux P; Cavelier F; Dubuc I; Vivet B; Costentin J; Martinez J
    J Med Chem; 2008 Mar; 51(6):1610-6. PubMed ID: 18321036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of a novel hexapeptide, (Me)Arg-Lys-Pro-Trp-tert-Leu-Leu-OEt, with neurotensin activity, in aqueous solution and in the solid state.
    Tokumura T; Tanaka T; Sasaki A; Tsuchiya Y; Abe K; Machida R
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3094-8. PubMed ID: 2085894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues.
    Sefler AM; He JX; Sawyer TK; Holub KE; Omecinsky DO; Reily MD; Thanabal V; Akunne HC; Cody WL
    J Med Chem; 1995 Jan; 38(2):249-57. PubMed ID: 7830267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly potent neurotensin analog that causes hypothermia and antinociception.
    Tyler-McMahon BM; Stewart JA; Farinas F; McCormick DJ; Richelson E
    Eur J Pharmacol; 2000 Feb; 390(1-2):107-11. PubMed ID: 10708713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties.
    Maes V; Garcia-Garayoa E; Bläuenstein P; Tourwé D
    J Med Chem; 2006 Mar; 49(5):1833-6. PubMed ID: 16509599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional activity of new C-terminal cyclic-neurotensin fragment analogs.
    Akunne HC; Darling S; Zoski K; Sefler AM; He JX; Sawyer TK; Pugsley TA; Cody WL
    Neuropeptides; 1996 Jun; 30(3):213-8. PubMed ID: 8819144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1).
    Akunne HC; Demattos SB; Whetzel SZ; Wustrow DJ; Davis DM; Wise LD; Cody WL; Pugsley TA; Heffner TG
    Biochem Pharmacol; 1995 Apr; 49(8):1147-54. PubMed ID: 7748196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational study of the neurotensin and substance P fragments: Pro-Arg-Arg-Pro and Arg-Pro-Lys-Pro.
    Cotrait M
    Int J Pept Protein Res; 1983 Jul; 22(1):110-8. PubMed ID: 6193076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo release of poly(DL-lactic acid) microspheres containing neurotensin analogue prepared by novel oil-in-water solvent evaporation method.
    Yamakawa I; Tsushima Y; Machida R; Watanabe S
    J Pharm Sci; 1992 Aug; 81(8):808-11. PubMed ID: 1403728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and binding of specifically mutated neurotensin fragments on a silver substrate: vibrational studies.
    Podstawka-Proniewicz E; Kudelski A; Kim Y; Proniewicz LM
    J Phys Chem B; 2011 Jun; 115(21):7097-108. PubMed ID: 21548565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of neurotensin receptors and purinoceptors in human colonic adenocarcinoma cells detected with the microphysiometer.
    Richards M; van Giersbergen P; Zimmermann A; Lesur B; Hoflack J
    Biochem Pharmacol; 1997 Oct; 54(7):825-32. PubMed ID: 9353137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological and biochemical characterization of processing products from the neurotensin/neuromedin N precursor in the rat medullary thyroid carcinoma 6-23 cell line.
    Bidard JN; de Nadai F; Rovere C; Moinier D; Laur J; Martinez J; Cuber JC; Kitabgi P
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):225-33. PubMed ID: 8471039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.
    Fantegrossi WE; Ko MC; Woods JH; Richelson E
    Pharmacol Biochem Behav; 2005 Feb; 80(2):341-9. PubMed ID: 15680187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of the novel anticonvulsant HEPP after single intravenous administration of three different doses in dogs.
    Gómez LE; Lehmann PA
    Biopharm Drug Dispos; 1995 Mar; 16(2):105-12. PubMed ID: 7780044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary structure of murine major histocompatibility alloantigens: amino acid sequence of the cyanogen bromide fragment Ia (positions 139-228) from the H-2Kb molecule.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Kindt TJ; Coligan JE
    Biochemistry; 1980 Dec; 19(26):6182-8. PubMed ID: 7470457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analogues.
    Heyl DL; Sefler AM; He JX; Sawyer TK; Wustrow DJ; Akunne HC; Davis MD; Pugsley TA; Heffner TG; Corbin AE
    Int J Pept Protein Res; 1994 Sep; 44(3):233-8. PubMed ID: 7822099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
    Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
    Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.